Akums Drugs and Pharmaceutical Cash Flow-to-Debt Ratio
Akums Drugs and Pharmaceutical cash flow-to-debt ratio. Akums Drugs and Pharmaceutical (AKUMS) has a Cash Flow-to-Debt Ratio of 0.58x as of September 2025, meaning its operating cash flow of Rs11.52 Billion could theoretically repay 1% of its total liabilities (Rs19.91 Billion) in one year. Check cash flow quality index of Akums Drugs and Pharmaceutical to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Akums Drugs and Pharmaceutical (2022–2026)
Cash flow-to-debt ratio of Akums Drugs and Pharmaceutical from 2022 to 2026. Historical debt coverage capacity for Akums Drugs and Pharmaceutical across 5 annual periods. Check AKUMS cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Akums Drugs and Pharmaceutical Cash Flow-to-Debt Ratio by Year (2022–2026)
Akums Drugs and Pharmaceutical cash flow-to-debt ratio by year from 2022 to 2026. Year-by-year debt coverage analysis for Akums Drugs and Pharmaceutical. For the full cash flow conversion analysis, see Akums Drugs and Pharmaceutical cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | 0.57x | Rs12.11 Billion | Rs21.16 Billion | ▲ +29.1% |
| 2025 | 0.44x | Rs4.65 Billion | Rs10.50 Billion | ▲ +148.6% |
| 2024 | 0.18x | Rs4.98 Billion | Rs27.96 Billion | ▲ +156.6% |
| 2023 | 0.07x | Rs1.77 Billion | Rs25.43 Billion | ▲ +432.9% |
| 2022 | 0.01x | Rs318.54 Million | Rs24.44 Billion | — |